You are now viewing our public site. Back to Dashboard

Details

  • video_library

    4 Courses

Elizabeth Galik

PhD, CRNP, FAAN, FAANP

Elizabeth Galik is a Professor at the University of Maryland School of Nursing. She received a BSN from the University of Pennsylvania, an MSN from Villanova University, a post-master's Adult Nurse Practitioner Certificate from Johns Hopkins University, and a PhD from the University of Maryland. Her research interest is in developing and testing interventions to improve functional performance, physical activity, and quality of life among older adults with dementia. Dr. Galik practices clinically as a nurse practitioner in community and long-term care settings and focuses on the medical and neuropsychiatric care of individuals with dementia. In addition to her research, she also teaches in the adult and geriatric nurse practitioner program. Dr. Galik was awarded a John A. Hartford Foundation pre-doctoral fellowship, and has received extramural research funding from the Alzheimer's Association, Foundation of the American Medical Directors' Association, and the American Academy of Nurse Practitioners. She is a Board Member of the Maryland Gerontological Association, and the President Elect for the Gerontological Advanced Practice Nurses Association. Her memberships include Sigma Theta Tau International, Phi Kappa Phi, Southern Nursing Research Society, Gerontological Association of America, and the American Academy of Nurse Practitioners.

verified Learn from Elizabeth Galik and 850+ other industry-leading experts.

Browse Plans

Courses with Elizabeth Galik

Browse Course Catalog

Minimizing the Use of Antipsychotics in Long-Term Care

Presented by Elizabeth Galik, PhD, CRNP, FAAN, FAANP

Minimizing the Use of Antipsychotics in Long-Term Care

Subscribe now, and access clinical education and patient education—anytime, anywhere—with video instruction from recognized industry experts.

Antipsychotic medications have been widely used to manage behavioral symptoms among older adults with dementia. The Centers for Medicare and Medicaid have launched a policy initiative to decrease the inappropriate use of antipsychotics in long-term care settings due to minimal effectiveness and risks associated with their use. Antipsychotic use now affects nursing homes' five-star quality rating score. This session will describe the appropriate use of antipsychotics and help nurses to monitor for potential side effects of these medications. Additionally, common challenges and practical solutions for antipsychotic reduction in long-term care settings will be discussed.

View full course details

Assessment and Treatment of Anxiety Disorders Among Older Adults

Presented by Elizabeth Galik, PhD, CRNP, FAAN, FAANP

Assessment and Treatment of Anxiety Disorders Among Older Adults

Subscribe now, and access clinical education and patient education—anytime, anywhere—with video instruction from recognized industry experts.
Video Runtime: 55 Minutes; Learning Assessment Time: 54 Minutes

Anxiety disorders are common among older adults, and symptom presentation differs from that of a younger population. The most common anxiety disorders among older adults include generalized anxiety disorder, panic disorder, anxiety due to a medical condition or medication, and phobias. Untreated or partially treated anxiety disorders are associated with increased functional disability, use of health services and medication use, and decreased cognition and quality of life. This session will describe the epidemiology and unique features of common anxiety disorders among older adults by utilizing case examples. Challenges associated with the assessment of anxiety symptoms and methods to overcome challenges will also be discussed. Additionally, the course will discuss the use of a variety of non-pharmacological and pharmacological interventions, including the importance of de-prescribing medications and substances that may aggravate underlying anxiety symptoms. Anxiety disorders among older adults can be effectively treated when individualized non-pharmacological and pharmacological strategies are utilized.

View full course details

Assessment and Management of Older Adults with Depression

Presented by Elizabeth Galik, PhD, CRNP, FAAN, FAANP

Assessment and Management of Older Adults with Depression

Subscribe now, and access clinical education and patient education—anytime, anywhere—with video instruction from recognized industry experts.
Video Runtime: 56 Minutes; Learning Assessment Time: 54 Minutes

Depression is one of the most common psychiatric disorders to affect older adults, and symptom presentation may be different among older adults compared to a younger population. Untreated or partially treated depression has a negative impact on the health and quality of life of older adults. This session will describe the prevalence of depression among older adults and will highlight the symptoms that are unique to this population. Assessment of older adults with depressive symptoms, including screening tools and the evaluation of suicide risk, will also be addressed. Additionally, the course will discuss the use of a variety of non-pharmacological and pharmacological interventions. Depression among older adults can be effectively treated when individualized non-pharmacological and pharmacological strategies are deployed.

View full course details

Antipsychotic Medications and Drug-Induced Movement Disorders

Presented by Elizabeth Galik, PhD, CRNP, FAAN, FAANP

Antipsychotic Medications and Drug-Induced Movement Disorders

Subscribe now, and access clinical education and patient education—anytime, anywhere—with video instruction from recognized industry experts.
Video Runtime: 39 Minutes; Learning Assessment Time: 39 Minutes

Antipsychotic medications are used among older adults to treat chronic psychiatric disorders such as schizophrenia and bipolar disorder and are also used off-label to treat symptoms of hyperactive delirium and behavioral symptoms in the context of dementia. Antipsychotic use requires ongoing monitoring for potential side effects such as sedation, elevated blood sugar, weight gain, and anticholinergic side effects, such as blurry vision, constipation, and orthostasis. Additionally, antipsychotics may also cause drug-induced movement disorders, some of which may be non-reversible. This session will describe the Food and Drug Administration (FDA)- approved and off-label uses of antipsychotics among older adults and will improve your skills in monitoring for potential side effects of these medications. Assessment of drug-induced movement disorders, such as Parkinsonism, dystonia, akathisia, and dyskinesias, will be emphasized through clinical examples and the use of standardized rating instruments.

View full course details

video_library

Start any course for free!

Get access to the first chapter of all 2600+ courses when you create a free account.

Sign Up for Free

Sign up to get free evidence-based articles, exclusive discounts, and insights from industry-leaders.

Join our newsletter to get the latest updates delivered straight to your inbox.

MedBridge blog posts and emails

Request a Demo

For groups of 5 or more, request a demo to learn about our solution and pricing for your organization. For other questions or support, visit our contact page.

Contact Sales

Contact sales to learn about our solution and pricing for your organization. For other questions or support, visit our contact page.